This information collection request
supports agency regulations at 21 CFR part 200.5 and the associated
agency guidance regarding "Dear Healthcare Provider" Letters.
Respondents to the collection are manufacturers and distributors of
drugs for which such a letter would be required as provided for in
our regulations. The letters communicate important information
about prescription drug and biological products (drugs).
The information collection
reflects an adjustment. We have reduced the number of respondents
by 17, which results in a corresponding decrease to the annual
burden hours by 1,200 and the annual number of disclosures by
12.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.